Clinical guidelines for sclerotherapy: implementation in actual practice

Introduction. The simplicity of the sclerotherapy procedure, its high efficiency and low cost along with the possibility of performing the procedure on an outpatient basis stimulate the widespread use of the method.

Objective of the study. Examine the current state of actual clinical practice regarding the treatment of patients with varicose veins using the sclerotherapy procedure.

Materials and methods. An anonymous survey of 162 doctors, members of the professional community of specialists engaged in the treatment of venous diseases was performed. It comprised 15 questions concerning the features of the sclerotherapy procedure and following up of the patients.

Results and discussion. The lack of clear-cut standardization for sclerotherapy in the regulatory documents contributes to the significant heterogeneity in the approaches of specialists to the performance of the procedure. The views on the use of sclerotherapy to remove perineal varicose veins (routinely performed only by 25.3% of physicians) and the upper extremity veins (less than 4%) turned out to be controversial. There were significant differences in the therapeutic approaches to the administration of anticoagulants by the patients (refusal in the procedure – 26.3% of respondents, discontinuation of drugs during sclerotherapy – 7.5%). Approximately a third of the respondents regularly exceed recommended 10 ml-volume of foam per session, there is no consensus on the choice of the needle diameter, drug concentration even in the similar clinical situations. About half of them have experience in using glucose as the sclerosant, every third – in using a transcutaneous laser, 5.6% – in using the mechanochemical obliteration techniques that are not currently certified in the Russian Federation. The use of compression therapy after sclerotherapy is not standardized; the regulatory documents provide contradictory durations of its use, which is due to the weakness of clinical research data on this issue. Up to 99% of physicians observe pigmentation, 83.2% – development of secondary telangiectasias and 60.2% – superficial necrosis in their practice. These circumstances arouse legal suspicion in relation to this type of treatment and the legal vulnerability of physicians. At the same time, physicians need to be more informed about the current requirements for some issues.

Conclusion. The current legislation regulating the practical aspects of the sclerotherapy considers it largely through the lens of medicine, ignoring a significant cosmetic component. It is necessary to work out the provisions describing the specifics of cosmetic manipulations performed by the phlebologists, and the need for more detailed familiarization with the regular updates of the guidelines.

1. Bogachev V.Yu. Sclerotherapy. Step by step. Telangiectasia. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2019;(1-2):52–58. (In Russ.) doi: 10.21518/1995-1477-2019-1-2-52-58.

2. Borsuk D.A., Burleva E.P., Ilyukhin E.A., Lobastov K.V., Pryadko S.I., Seliverstov E.I. Lower extremity varicose veins without chronic venous insufficiency: clinical guidelines. Мoscow; 2017. 87 с. (In Russ.) Available at: https://phlebology-sro.ru/upload/iblock/7de/klinicheskie-rekomendatsii-minzdrava-rfpo-vrv-bez-khvn-_2017_.pdf.

3. Stoyko Yu.M., Kirienko A.I., Zatevakhin I.I., Pokrovskiy A.V., Karpenko A.A., Zolotukhin I.A. et al. Diagnostics and Treatment of Chronic Venous Diseases: Guidelines of Russian Phlebological Association. Flebologiya = Flebologiya. Journal of Venous Disorders. 2018;(3):146–240. doi: 10.17116/

4. flebo20187031146.

5. Elderman J.H., Krasznai A.G., Voogd A.C., Hulsewé K.W., Sikkink C.J. Role of compression stockings after endovenous laser therapy for primary varicosis. J Vasc Surg Venous Lymphat Disord. 2014;2(3):289–296. doi: 10.1016/j.jvsv.2014.01.003.

6. Rabe E., Breu F.X., Cavezzi A., Smith C.P., Frullini A., Gillet J.L. et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29(6):338–354. doi: 10.1177/0268355513483280.

7. Venermo M., Saarinen J., Eskelinen E., Vähäaho S., Saarinen E., Railo M. et al. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins. Br J Surg. 2016;103(11):1438–1444. doi: 10.1002/bjs.10260.

8. van der Velden S.K., Biemans A.A., De Maeseneer M.G., Kockaert M.A., Cuypers P.W., Hollestein L.M. et al. Five-year results of a randomized clinical trial of conventional surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy in patients with great saphenous varicose veins. Br J Surg. 2015;102(10):1184–1194. doi: 10.1002/bjs.9867.

9. Davies H.O., Popplewell M., Darvall K., Bate G., Bradbury A.W. A review of randomized controlled trials comparing ultrasoundguided foam sclerotherapy with endothermal ablation for the treatment of great saphenous varicose veins. Phlebology. 2016;31(4):234–240. doi: 10.1177/0268355515595194.

10. Brittenden J., Cotton S.C., Elders A., Tassie E., Scotland G., Ramsay C.R. et al. Clinical effectiveness and costeffectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technol Assess. 2015;19(27):1–342. doi: 10.3310/hta19270.

11. Bertanha M., Jaldin R.G., Moura R., Pimenta R.E.F., Mariúba J.V.O., Lucio Filho C.E.P. et al. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial. JAMA Dermatol. 2017;153(12):1249–1255. doi: 10.1001/jamadermatol.2017.3426.

12. de Roos K.P., Groen L., Leenders A.C. Foam sclerotherapy: investigating the need for sterile air. Dermatol Surg. 2011;37(8):1119–1124. doi: 10.1111/j.1524-4725.2011.02044.x.

13. Breu F.X., Guggenbichler S., Wollmann J.C. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa. 2008;37(1):90–95. doi: 10.1024/0301-1526.37.1.90.

14. Gillet J.L. Neurological complications of foam sclerotherapy: fears and reality. Phlebology. 2011;26(7):277–279. doi: 10.1258/phleb.2011.011e04.

15. Rabe E., Partsch H., Hafner J., Lattimer C., Mosti G., Neumann M. et al. Indications for medical compression stockings in venous and lymphatic disorders: An evidencebased consensus statement. Phlebology. 2018;33(3):163–184. doi: 10.1177/0268355516689631.